Novartis International AG
Time frame: 1 December 2022 - 30 November 2023Article ‘Count’ and ‘Share’ for Novartis International AG based on listed parameters only.
The articles listed below published by authors from Novartis International AG, organized by journal and article, represent the research output in Count and Share according to the parameters selected above.
Journal | Count | Share |
---|---|---|
American Journal of Human Genetics |
1 | 0.55 |
Cancer Research |
1 | 1.00 |
Cell |
5 | 0.68 |
Cell Stem Cell |
2 | 0.47 |
Developmental Cell |
1 | 0.40 |
Genome Research |
1 | 0.10 |
Journal of Cell Biology |
1 | 0.04 |
Journal of Clinical Investigation |
1 | 0.16 |
Journal of Experimental Medicine |
1 | 0.03 |
Molecular Cell |
3 | 1.16 |
Molecular Psychiatry |
1 | 0.00 |
Nature |
6 | 0.42 |
Nature Biotechnology |
1 | 0.11 |
Nature Cell Biology |
2 | 0.14 |
Nature Chemical Biology |
4 | 1.66 |
Nature Communications |
20 | 5.43 |
Nature Genetics |
3 | 0.79 |
Nature Immunology |
1 | 0.01 |
Nature Neuroscience |
2 | 0.26 |
Nature Structural & Molecular Biology |
1 | 0.32 |
Neuron |
2 | 0.46 |
PLOS Biology |
1 | 0.02 |
Proceedings of the National Academy of Sciences of the United States of America |
2 | 0.15 |
Science |
1 | 0.74 |
Science Advances |
4 | 0.59 |
Science Translational Medicine |
3 | 3.00 |
The EMBO Journal |
3 | 0.87 |
Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.